Cellectar Biosciences to Present at the 37th Annual Roth Conference Mar 11, 2025 08:05AM
Cellectar Biosciences to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference Feb 5, 2025 08:05AM
Cellectar Biosciences (CLRB) Taps INC Research (INCR) to Oversee CLR Phase 2 in Multiple Myeloma, Select Hematologic Malignancies Nov 15, 2016 10:06AM
Cellectar Biosciences Announces INC Research as the CRO for the Phase II Trial of CLR 131 in Hematologic Malignancies; $2M NCI Grant Covers Half of Study Cost, with Potential Option to Pursue Addition Nov 15, 2016 10:00AM